Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in Heart Failure Trial (Val-HeFT)

Journal of the American Society of Echocardiography

Volumn 15, Issue 4, 2002, Pages 293-307

  Wong, Maylene ^a,e   Staszewsky, Lidia ^b   Volpi, Alberto ^b,c   Latini, Roberto ^b   Barlera, Simona ^b   Höglund, Christer ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Ospedale G Fornaroli   (Italy)

^d Stockholm Heart Center   (Sweden)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORE LABORATORY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE SIZE; HUMAN; MAJOR CLINICAL STUDY; QUALITATIVE ANALYSIS; QUALITY CONTROL; RANDOM SAMPLE; RECORDING; REPRODUCIBILITY; SAMPLE SIZE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ECHOGRAPHY; HEALTH CARE QUALITY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD;

ANGIOTENSIN RECEPTOR; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE; VALSARTAN;

DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RECEPTORS, ANGIOTENSIN; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; TETRAZOLES; VALINE; VENTRICULAR FUNCTION, LEFT;

EID: 0036548539     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/mje.2001.115103     Document Type: Article

References (17)

1. Felner JM, Blumenstein BA, Schlant RC, Carter AD, Alimurung BN, Johnson MJ, et al. Sources of variability in echocardiographic measurements. Am J Cardiol 1980;45:995-1004.
2. Kuccherer HF, Kee LL, Modin G, Cheitlin MD, Schiller NB. Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications. J Am Soc Echocardiogr 1991;4:203-14.
3. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Schindler D, Benedict C, et al, for the SOLVD Investigators. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy. Circulation 1995;91:2573-81.
4. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, et al, for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994;89:68-75.
5. Wong M, Johnson G, Shabetai R, Hughes V, Bhat G, Lopez B, et al, for the V-HeFT VA Cooperative Studies Group. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs Cooperative Studies V-HeFT I and II. Circulation 1993;87(suppl VI):VI65-70.
6. Wong M, Germanson T, Taylor WR, Cohen IS, Perry G, Baruch L, et al. Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multi-center reproducibility and detecting functional change. J Card Fail 2000;6:19-28.
7. Cohn JN, Tognoni G, Glazer RD, Spormann D, Hester A. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail 1999;5:155-60.
8. Sahn DJ, DeMaria A, Kisslo J, Weyman A, for the Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1071-83.
9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:258-67.
10. SPSS Base System User's Guide. Chicago, IL: SPSS, Inc; 1990. p. 226-9.
11. Motulsky H. Analyzing data with GraphPad Prism. San Diego, CA: GraphPad Software, Inc; 1999. p. 82-4.
12. Siegel S, Castellon NJ, editors. Statistica non parametrica. Guilford, CT: McGraw-Hill; 1992. p. 88-92.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
14. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-60.
15. Fleiss JL. The design and analysis of clinical experiments. 1st ed. New York: John Wiley; 1986. p. 212-36.
16. Bland JM, Altman DG. Measurement error. BMJ 1996;313:744.
17. Moyé LA. Central laboratory sampling plans and quality control in clinical trials. Control Clin Trials 1991;12:761-7.